NEW YORK (GenomeWeb News) – Caris Life Sciences today announced a distribution deal with IPS Genomix to provide patients access to Caris' tumor profiling service in certain Middle Eastern and African markets.

Caris' service, called Molecular Intelligence, uses multiple technologies, including immunohistochemistry, FISH/CISH, PCR, and next-generation sequencing, to provide actionable information to clinicians to develop a treatment plan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.